TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
The Europe Phage Therapy market was valued at US$ 156.7 million in 2024 and is projected to reach US$ 345.6 million by 2030, at a CAGR of 14.1% during the forecast period 2024-2030.
Therapeutic approach using bacteriophages to treat bacterial infections, particularly antibiotic-resistant strains. Includes customized phage preparations, delivery systems, and treatment protocols for various bacterial infections.
Healthcare sector leads 100%. France dominates 35%. Clinical trials growing 65%. Treatment efficacy 82%. Research investment increasing 48%. Regulatory framework developing. Personalized therapy expanding. Antimicrobial resistance driving adoption. Clinical applications broadening.
Report Includes
This report is an essential reference for who looks for detailed information on Europe Phage Therapy. The report covers data on Europe markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Europe major vendors¡¯ information. In addition to the data part, the report also provides overview of Phage Therapy, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user's requirements is also available.
This report aims to provide a comprehensive presentation of the Europe Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy. This report contains market size and forecasts of Phage Therapy in Europe, including the following market information:
We surveyed the Phage Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
• Germany
• United Kingdom
• France
• Italy
• Spain
• Netherlands
• Belgium
• DsDNA Bacteriophage
• SsDNA Bacteriophage
• SsRNA Bacteriophage
• Others
• Animal Health
• Human Health
• Agriculture
• Food Industry
• Others
• Pherecydes Pharma
• Fixed-Phage Limited
• Phagomed Biopharma GmbH
• Intralytix, Inc.
• Locus Biosciences
• Adaptive Phage Therapeutics
• Micreos Human Health
• TechnoPhage
• PhagoMed
• BiomX
Including or excluding key companies relevant to your analysis.
The report also provides analysis of leading market participants including:
• Key companies Phage Therapy revenues in Europe market, 2019-2024 (Estimated), ($ millions)
• Key companies Phage Therapy revenues share in Europe market, 2023 (%)
• Key companies Phage Therapy sales in Europe market, 2019-2024 (Estimated),
• Key companies Phage Therapy sales share in Europe market, 2023 (%)
Key Points of this Report:
• The depth industry chain includes analysis value chain analysis, porter five forces model analysis and cost structure analysis
• The report covers Europe and country-wise market of Phage Therapy
• It describes present situation, historical background and future forecast
• Comprehensive data showing Phage Therapy capacities, production, consumption, trade statistics, and prices in the recent years are provided
• The report indicates a wealth of information on Phage Therapy manufacturers
• Phage Therapy forecast for next five years, including market volumes and prices is also provided
• Raw Material Supply and Downstream Consumer Information is also included
• Any other user's requirements which is feasible for us
Reasons to Purchase this Report:
• Analyzing the outlook of the market with the recent trends and SWOT analysis
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
• Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
• Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
• Distribution Channel sales Analysis by Value
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• 1-year analyst support, along with the data support in excel format.
1.1 Product Overview and Scope of Phage Therapy
1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 DsDNA Bacteriophage
1.2.3 SsDNA Bacteriophage
1.2.4 SsRNA Bacteriophage
1.2.5 Others
1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Animal Health
1.3.3 Human Health
1.3.4 Agriculture
1.3.5 Food Industry
1.3.6 Others
1.4 Europe Market Growth Prospects
1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)
1.4.2 Europe Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Europe Production by Manufacturers (2019-2023)
3.2 Europe Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Europe Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Europe 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Europe Production
4.1.1 Europe Production YoY Growth Rate (2019-2023)
4.1.2 Europe Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Europe
5.1.1 Europe Consumption by Country
5.1.2 Europe Sales, Consumption, Export, Import (2019-2023)
5.1.1 Germany
5.2.2 United Kingdom
5.3.3 France
5.4.4 Italy
5.5.5 Spain
5.6.6 Netherlands
5.7.7 Belgium
6.1 Europe Production Market Share by Type (2019-2024)
6.2 Europe Revenue Market Share by Type (2019-2024)
6.3 Europe Price by Type (2019-2024)
7.1 Europe Production Market Share by Application (2019-2024)
7.2 Europe Revenue Market Share by Application (2019-2024)
7.3 Europe Price by Application (2019-2024)
8.1 Pherecydes Pharma
8.1.1 Pherecydes Pharma Corporation Information
8.1.2 Pherecydes Pharma Product Portfolio
8.1.3 Pherecydes Pharma Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 Pherecydes Pharma Main Business and Markets Served
8.1.5 Pherecydes Pharma Recent Developments/Updates
8.2 Fixed-Phage Limited
8.2.1 Fixed-Phage Limited Corporation Information
8.2.2 Fixed-Phage Limited Product Portfolio
8.2.3 Fixed-Phage Limited Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Fixed-Phage Limited Main Business and Markets Served
8.2.5 Fixed-Phage Limited Recent Developments/Updates
8.3 Phagomed Biopharma GmbH
8.3.1 Phagomed Biopharma GmbH Corporation Information
8.3.2 Phagomed Biopharma GmbH Product Portfolio
8.3.3 Phagomed Biopharma GmbH Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Phagomed Biopharma GmbH Main Business and Markets Served
8.3.5 Phagomed Biopharma GmbH Recent Developments/Updates
8.4 Intralytix, Inc.
8.4.1 Intralytix, Inc. Corporation Information
8.4.2 Intralytix, Inc. Product Portfolio
8.4.3 Intralytix, Inc. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Intralytix, Inc. Main Business and Markets Served
8.4.5 Intralytix, Inc. Recent Developments/Updates
8.5 Locus Biosciences
8.5.1 Locus Biosciences Corporation Information
8.5.2 Locus Biosciences Product Portfolio
8.5.3 Locus Biosciences Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Locus Biosciences Main Business and Markets Served
8.5.5 Locus Biosciences Recent Developments/Updates
8.6 Adaptive Phage Therapeutics
8.6.1 Adaptive Phage Therapeutics Corporation Information
8.6.2 Adaptive Phage Therapeutics Product Portfolio
8.6.3 Adaptive Phage Therapeutics Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Adaptive Phage Therapeutics Main Business and Markets Served
8.6.5 Adaptive Phage Therapeutics Recent Developments/Updates
8.7 Micreos Human Health
8.7.1 Micreos Human Health Corporation Information
8.7.2 Micreos Human Health Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Micreos Human Health Main Business and Markets Served
8.7.4 Micreos Human Health Recent Developments/Updates
8.8 TechnoPhage
8.8.1 TechnoPhage Corporation Information
8.8.2 TechnoPhage Product Portfolio
8.8.3 TechnoPhage Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 TechnoPhage Main Business and Markets Served
8.8.5 TechnoPhage Recent Developments/Updates
8.9 PhagoMed
8.9.1 PhagoMed Corporation Information
8.9.2 PhagoMed Product Portfolio
8.9.3 PhagoMed Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 PhagoMed Main Business and Markets Served
8.9.5 PhagoMed Recent Developments/Updates
8.10 BiomX
8.10.1 BiomX Corporation Information
8.10.2 BiomX Product Portfolio
8.10.3 BiomX Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 BiomX Main Business and Markets Served
8.10.5 BiomX Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Phage Therapy
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Europe Production, Revenue Forecast (2024-2030)
13.1 Europe Forecasted Consumption of by Country
14.1 Europe Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Europe Forecasted Production of by Type (2024-2030)
14.1.2 Europe Forecasted Revenue of by Type (2024-2030)
14.1.3 Europe Forecasted Price of by Type (2024-2030)
14.2 Europe Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Europe Forecasted Production of by Application (2024-2030)
14.2.2 Europe Forecasted Revenue of by Application (2024-2030)
14.2.3 Europe Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?
